Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intratracheal dexmedetomidine plus lidocaine for prevention of postoperative sore throat after thyroidectomy
ChiCTR2300074526Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine, lidocaine and sodium chloride in Post-extubation sore throat (POST) and dysphonia (4 arms), sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoints: Incidence of postoperative sore throat, Classification of postoperative sore throat and 2 more. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
dexmedetomidinelidocainesodium chloride
03
Conditions
Post-extubation sore throat (POST)dysphonia
Beyond the preview
Go deeper on ChiCTR2300074526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074526.